Stockscreener 앱 받기
2.41
1.69%
0.04
시간 외 거래:
2.43
0.02
+0.83%
전일 마감가:
$2.37
열려 있는:
$2.38
하루 거래량:
121.38K
Relative Volume:
1.38
시가총액:
$98.82M
수익:
$2.70M
순이익/손실:
$5.53M
주가수익비율:
21.91
EPS:
0.11
순현금흐름:
$-10.55M
1주 성능:
-1.23%
1개월 성능:
+3.43%
6개월 성능:
+13.15%
1년 성능:
+1.47%
1일 변동 폭
$2.31
$2.4698
1주일 범위
$2.31
$2.51
52주 변동 폭
$1.82
$3.09
Oramed Pharmaceuticals Inc Stock (ORMP) Company Profile
명칭
Oramed Pharmaceuticals Inc
전화
646-844-1164
주소
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY
ORMP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ORMP
Oramed Pharmaceuticals Inc
|
2.41 | 97.18M | 2.70M | 5.53M | -10.55M | 0.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Oramed Pharmaceuticals Inc Stock (ORMP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-01-12 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2022-02-18 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-04-20 | 개시 | Canaccord Genuity | Buy |
| 2021-02-09 | 개시 | National Securities | Buy |
| 2020-12-03 | 개시 | Alliance Global Partners | Buy |
| 2020-03-11 | 개시 | Aegis Capital | Buy |
| 2019-09-11 | 개시 | Ladenburg Thalmann | Buy |
| 2017-12-11 | 재개 | B. Riley FBR, Inc. | Buy |
| 2016-05-26 | 재확인 | FBR Capital | Outperform |
| 2015-12-01 | 재확인 | H.C. Wainwright | Buy |
| 2015-11-19 | 개시 | FBR Capital | Outperform |
| 2015-04-13 | 재개 | MLV & Co | Buy |
| 2014-01-30 | 재확인 | Aegis Capital | Buy |
| 2014-01-08 | 재확인 | Aegis Capital | Buy |
| 2014-01-08 | 개시 | MLV & Co | Buy |
| 2013-12-03 | 개시 | Aegis Capital | Buy |
모두보기
Oramed Pharmaceuticals Inc 주식(ORMP)의 최신 뉴스
Oramed Pharmaceuticals Inc. stock outlook for YEARJuly 2025 Sector Moves & Consistent Profit Trade Alerts - newser.com
What’s the recovery path for long term holders of Oramed Pharmaceuticals Inc.2025 Technical Overview & Real-Time Buy Signal Alerts - newser.com
Weiss Ratings Reaffirms Sell (D) Rating for Oramed Pharmaceuticals (NASDAQ:ORMP) - MarketBeat
Analyzing recovery setups for Oramed Pharmaceuticals Inc. investorsGold Moves & Free AI Powered Buy and Sell Recommendations - newser.com
How to track smart money flows in Oramed Pharmaceuticals Inc.July 2025 Pullbacks & Weekly Market Pulse Updates - newser.com
Will Oramed Pharmaceuticals Inc. stock outperform Dow Jones index2025 Sector Review & Safe Capital Preservation Plans - newser.com
Will Oramed Pharmaceuticals Inc. stock go up soon2025 Trading Volume Trends & AI Driven Stock Reports - newser.com
Is Oramed Pharmaceuticals Inc. stock affected by interest rate hikesWeekly Trade Summary & AI Optimized Trading Strategy Guides - newser.com
How supply chain issues affect Oramed Pharmaceuticals Inc. stockJuly 2025 Levels & Low Drawdown Momentum Ideas - newser.com
Is Oramed Pharmaceuticals Inc OJU1 a good long term investmentPrice Volatility Patterns & Free Double Digit Growth Tips - earlytimes.in
Oramed Pharmaceuticals Forms Golden Cross, Signaling Bullish Breakout Ahead - Markets Mojo
What analysts say about Oramed Pharmaceuticals Inc stockEarnings Season Recap & Small Budget Wealth Building - earlytimes.in
Oramed Pharmaceuticals completes first tranche of Scilex warrant repurchase - Investing.com
Oramed Pharm Completes Warrant Repurchase Agreement - TipRanks
How to forecast Oramed Pharmaceuticals Inc. trends using time seriesQuarterly Earnings Summary & Community Supported Trade Ideas - newser.com
What MACD signals say about Oramed Pharmaceuticals Inc.Weekly Trade Recap & Intraday High Probability Alerts - newser.com
Can Oramed Pharmaceuticals Inc. (OJU1) stock withstand sector downturnsSell Signal & Safe Entry Point Identification - newser.com
Can Oramed Pharmaceuticals Inc. stock attract ESG capital inflowsEarnings Risk Report & Free Community Supported Trade Ideas - newser.com
What institutional flow reveals about Oramed Pharmaceuticals Inc.2025 Market Overview & Free Accurate Trade Setup Notifications - newser.com
Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Short Interest Down 35.7% in September - MarketBeat
Will Oramed Pharmaceuticals Inc. bounce back from current supportWeekly Volume Report & Verified Stock Trade Ideas - newser.com
Can Oramed Pharmaceuticals Inc. stock deliver surprise earnings beatMarket Movers & Fast Exit Strategy with Risk Control - newser.com
Has Oramed Pharmaceuticals Inc. found a price floorJuly 2025 Pullbacks & Real-Time Chart Pattern Alerts - newser.com
Analyzing net buyer seller activity in Oramed Pharmaceuticals Inc.Buy Signal & Technical Pattern Based Signals - newser.com
Using RSI to spot recovery in Oramed Pharmaceuticals Inc.2025 Short Interest & Real-Time Volume Triggers - newser.com
Will Oramed Pharmaceuticals Inc. stock see PE expansionTrade Analysis Summary & Daily Profit Maximizing Tips - newser.com
Oramed Pharmaceuticals (ORMP) Receives $13 Million from Scilex f - GuruFocus
Scilex Holding Company Completes Repurchase of 3.13 Million Warrants from Oramed Pharmaceuticals for $13 Million - Quiver Quantitative
Scilex Holding Company Announces the Completion of the First Tranche of the Oramed Pharmaceuticals, Inc. Warrant Repurchase - Yahoo Finance
Oramed Pharmaceuticals Inc (ORMP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.74%
자본화:
|
볼륨(24시간):